Brief reportClozapine decreases smoking in patients with chronic schizophrenia
References (9)
- et al.
Decreased substance use in chronically psychotic patients treated with clozapine (letter)
Am J Psychiatry
(1994) - et al.
Rank transformations as a bridge between parametric and nonparametric statistics
American Statistician
(1981)
Cited by (196)
Impact of clozapine as the mainstay therapeutical approach to schizophrenia and substance use disorder: A retrospective inpatient analysis
2022, Psychiatry Research CommunicationsClozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review
2018, European NeuropsychopharmacologyCitation Excerpt :When applicable, study duration ranged from 8 (Wu et al., 2013, Wu and Lan, 2017) to 16 weeks (de Leon et al., 2005). Four of the studies were performed in inpatients (McEvoy et al., 1995; de Leon et al., 2005; Wu et al., 2013; Wu and Lan, 2017). FGAs and non-clozapine SGAs were used as a clozapine comparator in two studies (Wu et al., 2013, Wu and Lan, 2017).
Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort
2017, Progress in Neuro-Psychopharmacology and Biological PsychiatryPredictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy
2017, Addictive BehaviorsCitation Excerpt :Participants' antipsychotic treatment regimen was assessed at baseline by a clinician. Clozapine versus non-clozapine antipsychotic treatment was examined as a potential predictor of abstinence, as other studies have found clozapine treatment to improve substance use outcomes in general and smoking cessation outcomes in particular compared to other antipsychotic agents (George, Sernyak, Ziedonis, & Woods, 1995; McEvoy et al., 1995). Expired CO concentration at baseline (Bedfont Smokerlyzer, Kent, England), age of smoking initiation, years smoked, number of cigarettes smoked per day, percent change in number of cigarettes smoked per day from baseline to quit day, severity of nicotine dependence (total score on the Fagerstrom Test for Nicotine Dependence, FTND (Fagerstrom, 2012)), percent change in nicotine withdrawal symptom rating scale total score from baseline to quit day (Wisconsin Smoking Withdrawal Scale, WSWS (Welsch et al., 1999)), smoking expectancies (total score on the Tiffany Questionnaire of Smoking Urges, TQSU (Tiffany & Drobes, 1991)), self-reported motivation to quit smoking, and number of lifetime quit attempts were assessed for each participant.
Nicotinic modulation of salience network connectivity and centrality in schizophrenia
2017, Journal of Psychiatric Research